Myeloid-Specific Pck1 Deficiency Does Not Alter Aortic Root Atherosclerosis in Mice
Although myeloid-specific Pck1 deficiency reduced body weight, liver weight, and HDL-cholesterol levels in mice, it did not alter aortic root atherosclerosis, indicating that Pck1 is not an atherosclerosis modifier gene.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Imagine the human body as a bustling city where traffic jams (plaque buildup) in the main arteries can lead to a total gridlock, causing heart attacks. For years, scientists have been hunting for the specific "traffic rules" or "construction crews" that make these jams worse or better. In this study, researchers decided to investigate a specific suspect: a gene called Pck1.
Think of the Ath28.1 region of the mouse genome as a tiny, 217-kilobase "crime scene" on a chromosome. Inside this tiny neighborhood, there were only three houses (genes) that could possibly be the culprit: Zbp1, Pck1, and Pmepa1. The team had already cleared Zbp1 as a suspect in a previous investigation. Now, they turned their spotlight on Pck1, which acts like a factory manager inside cells, helping to convert raw materials into energy and building blocks.
To test if Pck1 was the mastermind behind the traffic jams, the scientists created a special group of mice. They didn't just remove the gene from the whole body (which would be fatal, like shutting down the city's power grid entirely). Instead, they used a genetic "scissor" to snip Pck1 only out of the myeloid cells—the immune system's "street sweepers" and "construction workers" (macrophages) that patrol the blood vessels.
They then gave these mice a double dose of trouble: a one-time injection of a virus (AAV) that supercharged their "bad cholesterol" levels, followed by 16 weeks of a "Western-style" diet (think greasy burgers and fries). The goal was to see if removing the Pck1 factory from the street sweepers would stop the plaque from forming.
The Big Surprise (and the Disappointment)
The results were a bit like a magic trick that went wrong. The scientists expected the street sweepers to behave differently, but instead, the whole city changed shape.
- The Weight Loss: Both male and female mice without Pck1 in their immune cells became significantly lighter. Their bodies weighed about 26–31% less than the control group. Their livers, the city's main processing plant, also shrank by 30–40%.
- The Cholesterol Mix-up: The "bad" cholesterol (non-HDL) dropped in the male mice, but stayed the same in the females. However, the "good" cholesterol (HDL) took a nosedive in both sexes, dropping by roughly 52–60%.
The Verdict on the Traffic Jams
Here is the most important part: despite all these changes in weight and cholesterol, the traffic jams didn't change.
When the researchers looked at the mice's aortic roots (the main highway exit), the size of the plaque lesions was exactly the same in the mice without Pck1 as it was in the normal mice.
- In female mice, the plaque area was statistically identical.
- In male mice, the plaque area was also statistically identical, even though their bad cholesterol was lower.
The study explicitly rules out the idea that Pck1 in immune cells is a major modifier of atherosclerosis in this specific model. The authors state clearly that Pck1 was not confirmed as an atherosclerosis modifier gene.
What's Left?
The researchers are left with a mystery. They know that Pck1 is missing from the immune cells, and they know the mice got thinner and had weird cholesterol levels, but the heart disease didn't get better or worse. It's possible that Pck1 in other parts of the body (like the blood vessel walls themselves) still plays a role, but this study didn't test that. There is still one untested house in that tiny crime scene neighborhood: Pmepa1.
In short, the study tried to see if turning off the Pck1 switch in the immune system would stop heart disease. The answer is a firm no. The switch didn't stop the plaque, even though it made the mice much lighter and changed their cholesterol numbers. The hunt for the true cause of the Ath28.1 trait continues, but Pck1 in the immune cells has been cleared of the charge of causing or preventing these specific arterial blockages.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.